ATAD2 and hepatocellular carcinoma: IHC staining of an independent sample set (n = 82) represented on tissue microarrays confirmed the over-expression of ATAD2 protein in 58.5% (48/82) of HCC patients (representative images shown in Figure 1D; IHC scores are shown in Supplementary Table 1).